Stay updated on Upadacitinib in Giant Cell Arteritis Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib in Giant Cell Arteritis Clinical Trial page.

Latest updates to the Upadacitinib in Giant Cell Arteritis Clinical Trial page
- Check5 days agoChange DetectedThe page now displays Revision: v3.5.3 instead of Revision: v3.5.2. This indicates a minor site update that does not alter the study details or eligibility information.SummaryDifference0.0%

- Check12 days agoChange DetectedThe page’s revision label was updated from v3.5.0 to v3.5.2. No study details were changed.SummaryDifference0.0%

- Check19 days agoChange DetectedThe location entries were updated to include 'State of Vienna' as the state designation and 'Vienna, State of Vienna, Austria, 1100' as a new location, replacing the previous 'Vienna' and 'Vienna, Vienna, Austria, 1100' entries.SummaryDifference0.1%

- Check41 days agoChange DetectedRevision indicator updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.0%

- Check57 days agoChange DetectedRevision: v3.4.3 replaces the previous v3.4.2.SummaryDifference0.0%

- Check64 days agoChange DetectedEnrollment figures and key study dates were updated (e.g., 429 and dates like 2019-01-24, 2025-03-11, and 2026-02-04), and the interim safety/efficacy data through 06 February 2024 was removed.SummaryDifference0.1%

Stay in the know with updates to Upadacitinib in Giant Cell Arteritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib in Giant Cell Arteritis Clinical Trial page.